Trial intelligence / Profile preview

Varenicline Flexible Quit Date Study

NCT00691483Phase 4Completed

Sponsor
Pfizer
Start
Sep 2008
Primary completion
Sep 2009
Modality
Small Molecules
Countries
14
01

Overview

A Phase 4 trial of varenicline in nicotine dependence, sponsored by Pfizer. Started Sep 2008; status: completed.

02

Drugs

varenicline
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT00691483.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00691483.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call